Dirk Pühringer

Title: Dirk Pühringer: Innovator in Monoclonal Antibodies

Introduction

Dirk Pühringer is a notable inventor based in Rimpar, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, his work focuses on innovative solutions for treating cancer cachexia and cancer.

Latest Patents

Pühringer's latest patents include groundbreaking research on monoclonal antibodies to growth and differentiation factor 15 (GDF-15). These antibodies are designed for use in treating cancer cachexia and cancer. The inventions encompass chimeric antibodies and humanized antibodies, as well as murine antibodies. His work also provides pharmaceutical compositions, kits, methods, and cell lines capable of producing these monoclonal antibodies.

Career Highlights

Throughout his career, Dirk Pühringer has been associated with prestigious institutions such as Julius-Maximilians-Universität Würzburg. His research has significantly advanced the understanding and treatment of cancer-related conditions.

Collaborations

Pühringer has collaborated with esteemed colleagues, including Jörg Wischhusen and Markus Junker. These partnerships have further enriched his research and contributions to the field.

Conclusion

Dirk Pühringer's innovative work in monoclonal antibodies positions him as a key figure in biotechnology. His patents and collaborations reflect his commitment to advancing cancer treatment methodologies.